Year Wise Statistics
Total Downloads
452,220
Fulltext
218,842
PDF
233,378
452,220
Fulltext
218,842
233,378
| Articles | Fulltext downloads | PDF downloads | Total downloads |
|---|---|---|---|
Review ArticleAntibody-drug conjugate review in breast cancer: A targeted approachFull text |  PDF Volume 9 | Issue 3 | September-December 2024DOI: 10.25259/IJMIO_30_2024 |
12,141 | 35,487 | 47,628 |
Review ArticleGenetic diversity and variation in chronic myeloid leukemia patients of Indian origin- Implications for treatment response and prognosisFull text | PDF Volume 9 | Issue 3 | September-December 2024DOI: 10.25259/IJMIO_11_2024 |
11,661 | 29,898 | 41,559 |
Case ReportCase report – Muir–Torre syndrome – A skin-deep manifestation of underlying malignancyFull text | PDF Volume 9 | Issue 3 | September-December 2024DOI: 10.25259/IJMIO_26_2024 |
11,512 | 24,666 | 36,178 |
Review ArticleEmerging strategies in cancer immunotherapy: Expanding horizons and future perspectivesFull text | PDF Volume 9 | Issue 3 | September-December 2024DOI: 10.25259/IJMIO_24_2024 |
12,834 | 17,492 | 30,326 |
Case ReportBreast carcinoma disguised as systemic sclerosis: A case report of unusual paraneoplastic syndromeFull text | PDF Volume 10 | Issue 1 | January-April 2025DOI: 10.25259/IJMIO_4_2024 |
7,822 | 17,484 | 25,306 |
Short CommunicationOutcome of ivermectin and doxycycline in cancer patients with COVID-19: A positive experience in BangladeshFull text | PDF Volume 6 | Issue 1 | January-April 2021DOI: 10.25259/IJMIO_30_2020 |
22,686 | 720 | 23,406 |
Review ArticlePatient perspectives on living with chronic myeloid leukemia in India: Quality of life, psychosocial support, and stigmaFull text | PDF Volume 9 | Issue 3 | September-December 2024DOI: 10.25259/IJMIO_17_2024 |
11,742 | 578 | 12,320 |
EditorialThe cost-effectiveness of chronic myeloid leukemia treatment strategies in the Indian healthcare contextFull text | PDF Volume 9 | Issue 3 | September-December 2024DOI: 10.25259/IJMIO_14_2024 |
11,689 | 420 | 12,109 |
Original ArticleThe impact of myeloma induction therapy on stem cell mobilization and collection: ‘Daratumumab,’ a boon or a bane?Full text | PDF Volume 9 | Issue 3 | September-December 2024DOI: 10.25259/IJMIO_16_2024 |
11,302 | 433 | 11,735 |
From the Editor’s DeskYear End MessageFull text | PDF Volume 9 | Issue 3 | September-December 2024DOI: 10.25259/IJMIO_35_2024 |
11,274 | 324 | 11,598 |
Review ArticleEndocrine toxicity of cancer immunotherapyFull text | PDF Volume 9 | Issue 2 | May-August 2024DOI: 10.25259/IJMIO_19_2024 |
9,919 | 694 | 10,613 |
Short CommunicationDriver mutations in oncogenesisFull text | PDF Volume 6 | Issue 2 | May-August 2021DOI: 10.25259/IJMIO_26_2020 |
5,276 | 1,245 | 6,521 |
Review ArticleEfficacy and safety of cetuximab sarotalocan in recurrent/locally advanced head-and-neck cancer: A comprehensive reviewFull text | PDF Volume 9 | Issue 2 | May-August 2024DOI: 10.25259/IJMIO_9_2024 |
5,308 | 677 | 5,985 |
Case ReportImmature teratoma of the ovary: A Pandora’s box-an oncologist’s perspectiveFull text | PDF DOI: 10.25259/IJMIO_1_2025 |
1,629 | 2,305 | 3,934 |
Original ArticleSpectrum of lymphomas in IndiaFull text | PDF Volume 9 | Issue 1 | January-April 2024DOI: 10.25259/IJMIO_18_2023 |
1,888 | 1,250 | 3,138 |
Review ArticleIs continuous infusion of high-dose ifosfamide, a safe option? Drug reviewFull text | PDF Volume 5 | Issue 2 | May-August 2020DOI: 10.25259/IJMIO_21_2019 |
1,279 | 1,196 | 2,475 |
Brief CommentaryBreast cancer prognostic tools: A promising Indian optionFull text | PDF Volume 5 | Issue 2 | May-August 2020DOI: 10.25259/IJMIO_15_2020 |
1,012 | 1,286 | 2,298 |
Review ArticleMolecular genetics changes in gallbladder carcinomaFull text | PDF Volume 5 | Issue 2 | May-August 2020DOI: 10.25259/IJMIO_19_2019 |
1,021 | 1,177 | 2,198 |
NewsEditorial board tribute to Dr. Amit VermaFull text | PDF Volume 6 | Issue 3 | September-December 2021 |
759 | 1,333 | 2,092 |
Review ArticleThe Cancer Genomic Atlas – “TO CONQUER CANCER”Full text | PDF Volume 6 | Issue 2 | May-August 2021DOI: 10.25259/IJMIO_28_2020 |
781 | 1,207 | 1,988 |
Review ArticleCan CDK 4/6 inhibitors be used in patients with visceral crises? Deviating from conventional teachingFull text | PDF Volume 7 | Issue 2 | May – August 2022DOI: 10.25259/IJMIO_8_2022 |
750 | 1,190 | 1,940 |
Original ArticlePrevalence of germline mutations in women with breast and/or ovarian cancer in a tertiary care center in Pune, IndiaFull text | PDF Volume 8 | Issue 2 | May-August 2023DOI: 10.25259/IJMIO_5_2023 |
1,000 | 934 | 1,934 |
Case ReportClinical experience of total body irradiation performed on Halcyon™ for a patient diagnosed with acute myeloid leukemiaFull text | PDF Volume 7 | Issue 2 | May – August 2022DOI: 10.25259/IJMIO_5_2022 |
675 | 1,173 | 1,848 |
Review ArticleA compendium of population wide DNA methylation profile for oral cancer in IndiaFull text | PDF Volume 6 | Issue 2 | May-August 2021DOI: 10.25259/IJMIO_2_2021 |
672 | 1,076 | 1,748 |
Cardio Oncology with ACOSImmune checkpoint inhibitor-induced acute fulminant myocarditis: A case report and review of literatureFull text | PDF Volume 10 | Issue 1 | January-April 2025DOI: 10.25259/IJMIO_33_2024 |
1,079 | 657 | 1,736 |
Review ArticleMolecular targets in urinary bladder cancerFull text | PDF Volume 7 | Issue 3 | September-December 2022DOI: 10.25259/IJMIO_4_2022 |
730 | 991 | 1,721 |
Original ArticleReal-world study on the effect of nab-paclitaxel treatment on clinical outcomes and laboratory parameters in patients across metastatic tumor sitesFull text | PDF Volume 9 | Issue 2 | May-August 2024DOI: 10.25259/IJMIO_5_2024 |
802 | 887 | 1,689 |
Review ArticleClinical trials landscape in Sri LankaFull text | PDF Volume 6 | Issue 2 | May-August 2021DOI: 10.25259/IJMIO_29_2020 |
841 | 845 | 1,686 |
Cardio Oncology with ACOSIbrutinib and atrial fibrillation as cardiotoxicity – A new safety warning that impacts overall survivalFull text | PDF Volume 7 | Issue 2 | May – August 2022DOI: 10.25259/IJMIO_1_2022 |
595 | 1,087 | 1,682 |
Review ArticleRole of stem cell transplant in chronic myeloid leukemia in contemporary settingsFull text | PDF Volume 10 | Issue 1 | January-April 2025DOI: 10.25259/IJMIO_15_2024 |
1,053 | 626 | 1,679 |
Case ReportGastric cancer or hodgkin lymphoma? Unraveling the diagnostic dilemma of primary gastric classical hodgkin lymphomaFull text | PDF Volume 10 | Issue 1 | January-April 2025DOI: 10.25259/IJMIO_28_2024 |
1,043 | 613 | 1,656 |
Review ArticleImmune dynamics of SARS-CoV-2 virus evolutionFull text | PDF Volume 7 | Issue 1 | January-April 2022DOI: 10.25259/IJMIO_26_2021 |
663 | 981 | 1,644 |
Case ReportNUTM1-BRD4 fusion mutation-positive salivary gland myoepithelial carcinoma: A diagnostic conundrumFull text | PDF Volume 10 | Issue 1 | January-April 2025DOI: 10.25259/IJMIO_2_2025 |
1,022 | 594 | 1,616 |
Review ArticleHigh-dose nicotinamide, a histone deacetylase inhibitor (Sirtuin-1), can prevent emergence of treatment resistance in chronic myeloid leukemia – A perspectiveFull text | PDF Volume 9 | Issue 1 | January-April 2024DOI: 10.25259/IJMIO_1_2024 |
660 | 944 | 1,604 |
Case ReportSquamous cell carcinoma of lung presenting as “Sunray sign” in chest radiographFull text | PDF Volume 8 | Issue 3 | September-December 2023DOI: 10.25259/IJMIO_6_2023 |
828 | 756 | 1,584 |
Case ReportComplete metabolic response with letrozole and palbociclib in advanced breast cancerFull text | PDF Volume 4 | Issue 3 | September-December 2019DOI: 10.25259/IJMIO_2_2019 |
641 | 917 | 1,558 |
Review ArticleImmuno-oncology of differentiated thyroid cancerFull text | PDF Volume 6 | Issue 2 | May-August 2021DOI: 10.25259/IJMIO_36_2020 |
532 | 994 | 1,526 |
EditorialCrucial crossroads: Making the right choice for first-line therapy in advanced urothelial cancerFull text | PDF Volume 9 | Issue 1 | January-April 2024DOI: 10.25259/IJMIO_2_2024 |
432 | 1,087 | 1,519 |
Review ArticleRedefining treatment-free remission criteria in chronic myeloid leukemia in IndiaFull text | PDF Volume 10 | Issue 1 | January-April 2025DOI: 10.25259/IJMIO_10_2024 |
1,488 | 31 | 1,519 |
Original ArticleMultiple gene silencing in STAT pathway in K562 cellsFull text | PDF Volume 4 | Issue 1 | January-April 2019DOI: 10.25259/IJMIO-5-2019 |
582 | 936 | 1,518 |
Short CommunicationOutcome of ivermectin and doxycycline in cancer patients with COVID-19: A positive experience in BangladeshFull text | PDF Volume 6 | Issue 1 | January-April 2021DOI: 10.25259/IJMIO_30_2020 |
623 | 889 | 1,512 |
Original ArticleTriple-negative breast cancer in India: Exploring age distribution and laterality patternsFull text | PDF Volume 9 | Issue 2 | May-August 2024DOI: 10.25259/IJMIO_12_2024 |
977 | 532 | 1,509 |
Review ArticleImmuno-oncological era of breast cancer: A progressive path to better treatmentFull text | PDF Volume 7 | Issue 2 | May – August 2022DOI: 10.25259/IJMIO_3_2022 |
552 | 956 | 1,508 |
Review ArticleUse of five-day chronomodulated prescription of palbociclib as myelopreservation drug along with Topotecan in recurrent extensive stage small cell lung carcinoma – A perspective articleFull text | PDF Volume 9 | Issue 1 | January-April 2024DOI: 10.25259/IJMIO_3_2024 |
507 | 1,000 | 1,507 |
Review ArticleAlpha-fetoprotein: A molecular bootstrap for hepatocellular carcinomaFull text | PDF Volume 5 | Issue 3 | September-December 2020DOI: 10.25259/IJMIO_5_2020 |
786 | 678 | 1,464 |
Case ReportCHEK2 gene in metastatic prostate cancer: A cordial check on DNA damage repair pathwayFull text | PDF Volume 8 | Issue 1 | January-April 2023DOI: 10.25259/IJMIO_25_2022 |
997 | 452 | 1,449 |
Case ReportUnusual presentation of an Epstein barr virus-negative extranodal natural killer/T cell lymphoma: A diagnostic dilemmaFull text | PDF Volume 7 | Issue 1 | January-April 2022DOI: 10.25259/IJMIO_18_2021 |
504 | 942 | 1,446 |
Original ArticleEvaluating the levels of D-dimer as a primary marker in oral cancers using immunoturbidimetric assay: The original researchFull text | PDF Volume 5 | Issue 3 | September-December 2020DOI: 10.25259/IJMIO_11_2020 |
635 | 760 | 1,395 |
Case ReportA FANCA mutation carrier with enhanced toxicity to cancer directed treatment – A case report and review of literatureFull text | PDF Volume 8 | Issue 2 | May-August 2023DOI: 10.25259/IJMIO_1_2023 |
567 | 811 | 1,378 |
Review ArticleImpact of 2013 ASCO/CAP guidelines on various HER2 reporting categories in breast cancer by fluorescent in-situ hybridization and Immunohistochemistry: A meta-analysis with systematic reviewFull text | PDF Volume 5 | Issue 1 | January-April 2020DOI: 10.25259/IJMIO_17_2019 |
526 | 849 | 1,375 |
